Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis

BACKGROUND: Anti-granulocyte–macrophage colony-stimulating factor autoantibody (GMAb) has been recognized as a diagnostic biomarker for autoimmune pulmonary alveolar proteinosis (aPAP). The aims of this study were to know the incidence of increased level of serum GMAb in granulomatous lung diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Kanako, Hirose, Masaki, Arai, Toru, Hatsuda, Kazuyoshi, Tachibana, Kazunobu, Sugawara, Reiko, Sugimoto, Chikatoshi, Kasai, Takahiko, Akira, Masanori, Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525969/
https://www.ncbi.nlm.nih.gov/pubmed/32993757
http://dx.doi.org/10.1186/s13023-020-01546-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525969/
https://www.ncbi.nlm.nih.gov/pubmed/32993757
http://dx.doi.org/10.1186/s13023-020-01546-x

Ejemplares similares